Skip to content

Evaluation of MyoStrain™ in Clinical Practice

Evaluation of MyoStrain™ in Clinical Practice

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03825224
Enrollment
19
Registered
2019-01-31
Start date
2019-04-15
Completion date
2019-11-15
Last updated
2019-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Amyloidosis, Cardiac Failure, Coronary Artery Disease, Drug Toxicity, Lupus, Myocarditis, Sarcoidosis

Keywords

MRI, SENC MyoStrain

Brief summary

Evaluate MyoStrain cardiac MRI pulse sequence in Clinical practice

Detailed description

Evaluate MyoStrain cardiac MRI pulse sequence in Clinical practice to determine how the use may alter treatment decisions and clinical outcomes in patients who are undergoing cardiac MRI.

Interventions

PROCEDUREDiagnostic Test: Myostrain

This test measures the contraction of the heart muscle in one to three heartbeats per plane. It's a pulse sequence that produces images that reveal the underlying contraction fo the muscle of a healthy heart and associated weaknesses in case of disease.

Sponsors

University of Kansas Medical Center
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL

Inclusion criteria

* Patients already scheduled for diagnostic testing with commercially available imaging modality (cardiac MRI) * The patient population will include (but not limited to), those being evaluated for heart disease and heart failure that may be related to vascular disease (coronary artery disease), drug related heart failure (chemotherapy, alcohol), inflammatory systemic conditions (sarcoidosis, amyloidosis, lupus), myocarditis, and/or infectious etiologies * Provided written informed consent

Exclusion criteria

* Contraindication to Magnetic Resonance Imaging

Design outcomes

Primary

MeasureTime frameDescription
Evaluate workflow for MyoStrain testingBaselineSurvey the CMR interpreter to see how Myostrain impacted their interpretation and survey the referring clinician after receiving the CMR report. Survey Questions using 5-point Likert and binary reporting scale. The lower numbers represent positive feedback. Example listed below: CARDIAC MRI INTERPRETATION QUESTIONS FOR READER (CARDIOLOGIST OR RADIOLOGIST) How easy was it to interpret the additional Myostrain sequence information? 1 2 3 4 5 (1=Very Helpful 2=Helpful 3=Indifferent 4=Unhelpful 5=Very Unhelpful)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026